PLX
Protalix BioTherapeutics, Inc. Common Stock
stockNYSEAMERICAN
At CloseOct 30, 2026 4:32:30 PM EDT
2.56USD-1.916%(-0.05)249,288
Pre-marketOct 30, 2026 10:26:02 AM EDT
2.59USD-0.766%(-0.02)
PLX Financials
In Q2 FY 2026 (ended ), Protalix BioTherapeutics, Inc. Common Stock (PLX) reported revenue of $19.9M, net income of $3.78M, operating cash flow of −$10.4M, and assets of $110.34M.
Loading financial statements…